Home › Blood Cancers › NCT05112614
Role of Gut Microbiome in Cancer Therapy
RecruitingObservational study
Who can join
Ages 18 to 99 · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 18-99 * Diagnosis of cancer and undergoing cancer therapy or scheduled to start cancer therapy or undergoing stem cell transplant for any hematological condition Exclusion Criteria: * Unable to provide informed consent * Vulnerable adults
About the study
This study examines how gut microbiome can affect cancer therapy in cancer patients undergoing cancer therapy or stem cell transplant. The human microbiome affects the way some cancer drugs are metabolized in the human body. Information from this study may help doctors improve the way cancer treatment is delivered, and increase its effectiveness and success.
What is being tested
- Biospecimen Collection (procedure)
- Electronic Health Record Review (other)
Sponsor: Mayo Clinic · Participants: 3,000 · Started: Sep 11, 2019
Contact the study team
- Clinical Trials Referral Office · Phone: 855-776-0015
Official record on ClinicalTrials.gov — NCT05112614
Locations in the U.S.
| Minnesota | Mayo Clinic in Rochester, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.